Sentences with phrase «research sickle cell»

Dr. Buchanan has led the institutional pediatric and research sickle cell disease programs for 37 years.

Not exact matches

Government funding for research into sickle - cell disease is pitifully inadequate (the Sickle - Cell Society receives no government funds atsickle - cell disease is pitifully inadequate (the Sickle - Cell Society receives no government funds at acell disease is pitifully inadequate (the Sickle - Cell Society receives no government funds atSickle - Cell Society receives no government funds at aCell Society receives no government funds at all).

Do your research about Sickle cell and you'll see.

For his part, Collins, who has led NIH since 2009 and been kept on by the Trump administration, pointed to an array of promising NIH activities, including the development of new technologies to provide insights into human brain circuitry and function through the Brain Research through Advancing Innovative Neuroethologies (BRAIN initiative) and the use of the gene - editing tool CRISPR - Cas9 to correct mutations and clear the way to develop and test a «curative therapy» for the first molecular disease: sickle cell disease.

«The aim is to improve the care of all people with sickle cell disease, young and old, and to raise awareness among the entire medical profession regarding the need for better care and more research, so that someday everyone with sickle cell disease can receive the best possible care and lead a normal and productive life,» said Dr. George Buchanan, Professor of Pediatrics and Internal Medicine.

Many of them were babies, and a few suffered from the hematologic disorders that have been the focus of Daley's research — diseases like Fanconi's anemia, thalassemia, sickle - cell anemia, and childhood leukemias.

National Institutes of Health Director Francis Collins delivered an upbeat assessment of what lies in store for the world's largest supporter of biomedical research, projecting advances in battling genetic disorders such as sickle cell disease and the development of an atlas of human cells to...

Vanderbilt - led research, as part of an international, multicenter trial, found regular blood transfusion therapy significantly reduces the recurrence of silent strokes and strokes in children with sickle cell anemia who have had pre-existing silent strokes, according to study results released today in the New England Journal of Medicine (NEJM).

New preclinical research on the molecular mechanisms responsible for sickle cell disease could aid efforts to develop much needed treatments for this devastating blood disorder that affects millions worldwide.

An international research team led by biochemists at The University of Texas Health Science Center at Houston (UTHealth) reduced the sickling of red blood cells in a mouse model of the disease.

Rod Kellems, Ph.D., study co-author and chairman of the Department of Biochemistry and Molecular Biology at the UTHealth Medical School, added, «This research provides insight into how red blood cells work, revealing that SphK1 - mediated elevation of S1P contributes to sickling and promotes disease progression and highlights potential therapeutic opportunities for sickle cell disease.»

Research from the 1980s found that there are actually four types of sickle red blood cells, and not all of them are rigid and sickle - shaped.

By forcing adult mice with sickle cell disease to produce a fetal version of the hemoglobin molecule that carries oxygen in blood, a research team has eliminated symptoms of disorder in the animals.

«Previous research identified pain and sleep disturbance as two common symptoms of adult sickle cell disorder,» said Sunil Sharma, M.D., Associate Professor of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University and first author on the study.

Dr. Haywood conducts empirical bioethics and health services research related to sickle cell disease.

At the federal level, Dr. Haywood serves on a National Human Genome Research Institute sponsored working group charged with examining the evidence regarding the clinical implications of sickle cell carrier status.

Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern - raising behaviors, preliminary model, and agenda for international collaborative research to inform practice.

From birth to adulthood, we help patients live with sickle cell disease, while we continue to research new cures and better long - term care.

Scientists developing new cell therapy methods for the treatment of disorders such as sickle cell disease or leukemia need to consider how their culture conditions may affect the success of their translational research.

Currently with St. Jude Children's Research Hospital, Cunningham has led research that expands medical understanding of sickle cell anemia and thalResearch Hospital, Cunningham has led research that expands medical understanding of sickle cell anemia and thalresearch that expands medical understanding of sickle cell anemia and thalassemia.

Multiple research groups and companies are hot on the tracks of unleashing CRISPR on sickle cell disease, hemophilia, cystic fibrosis, Duchenne muscular dystrophy, genetic forms of blindness, and, of course, cancer.

Stem cell researchers are getting closer to a new treatment for sickle cell disease, moving promising laboratory research into human clinical trials.

Children receiving care at Texas Children's Sickle Cell Program have the opportunity to participate in several National Institutes of Health (NIH)- funded research studies led by physician scientists, providing the latest treatments for this disease.

The Sickle Cell Program conducts state - of - the - art clinical and laboratory research aimed at gaining a better understanding of the disease, preventing its complications and ultimately finding a cure.

Tags: Joseph Rosenthal, Pediatrics, childhood cancer, immunotherapy, pediatric cancer, pediatric cancers, pediatric research, sickle cell

Research team's multiscale scheme captures blood disorder's key molecular details Each year, 500,000 babies are born with a genetic disorder called sickle cell disease, a...

She is currently conducting research on the theoretical foundations of respect and the impact of physician attitudes and patient - physician communication on patients in the primary care setting, in the treatment of HIV and substance abuse, and in the treatment of sickle cell disease.

Buchanan, who wasn't involved in the research, helped craft the current treatment guidelines for sickle cell.

This booklet has been produced based on research into young people with sickle cell disorder in schools in England.

For example, we know that African Americans are disproportionately affected by sickle cell disease, so if research proposals to control sickle cell were systematically turned down, one might argue that this is racially discriminatory, because of the disparate impact of the policy.

Presentations & Publications Senior Research Seminar, St. Vincent's Medical Center (Bridgeport, CT) 1996 «Treatment of Failed Hemodialysis Access Sites: Comparison of Surgical Treatment with Thrombolysis / Percutaneous Angioplasty» American College of Physicians, Connecticut Chapter Spring Scientific Session 1996 «Treatment of Failed Hemodialysis Access Sites: Comparison of Surgical Treatment with Thrombolysis / Percutaneous Angioplasty» American College of Physicians, Connecticut Chapter Spring Scientific Session 1995 «Spinal Cord Infarction Secondary to Well Differentiated Lymphocytic Lymphoma» A Case Report American College of Physicians, Connecticut Chapter Spring Scientific Session 1995 «Acute Chest Syndrome in Sickle Cell Disease» A Case Report

Today academic institutions and teaching hospitals across the country receive federal or private grants to support groundbreaking research using human fetal tissue on a wide range of conditions including diabetes, Parkinson's disease, Alzheimer's disease, spinal cord injuries, hemophilia, leukemia, sickle cell anemia, cortical blindness, fetal aneuploidy, ALS, and others.

Particularly cynical and ugly questions about whether tissue from African - American patients could be isolated to use for research to find a cure for sickle - cell anemia, presumably to edit deceptively and manufacture false and inflammatory video involving race.